You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune thrombocytopenia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

Enrolling by invitation
  • Refractory Systemic Lupus Erythematosus
  • +2 more
  • CNCT19 cell injection
  • Peking, China
    Xiaofeng Zeng
Jul 3, 2023

Activity and Safety of Fostamatinib in Consecutive Adult ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • +2 more
  • (no location specified)
Jan 12, 2023

Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

Recruiting
  • Immune Thrombocytopenia
  • Suzhou, Jiangsu, China
    Jie Yin
Apr 19, 2022

Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)

Not yet recruiting
  • Chronic Primary Immune Thrombocytopenia (ITP)
  • Bengbu, Anhui, China
  • +13 more
Aug 15, 2023

Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

Not yet recruiting
  • Immune Thrombocytopenia
  • Pregnancy Related
  • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
  • intravenous immunoglobulin
  • (no location specified)
Dec 1, 2022

Immune Thrombocytopenia Trial (VIT D)

Not yet recruiting
  • Immune Thrombocytopenia
  • VIT D
  • (no location specified)
Oct 5, 2023

Immune Thrombocytopenia Trial in Beijing (Prednisone, Recombinant Human TPO)

Recruiting
  • Immune Thrombocytopenia
  • Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 17, 2022

Primary Immune Thrombocytopenia Trial in Guadalajara (Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet)

Completed
  • Primary Immune Thrombocytopenia
  • Atorvastatin 40 Mg Oral Tablet + N-acetylcysteine 400 mg Oral tablet
  • Guadalajara, Jalisco, Mexico
    Hospital Civil de Guadalajara Fray Antonio Alcalde
Sep 20, 2022

Primary Immune Thrombocytopenia Trial in China (Orelabrutinib( lower dose), Orelabrutinib( higher dose))

Recruiting
  • Primary Immune Thrombocytopenia
  • Orelabrutinib( lower dose)
  • Orelabrutinib( higher dose)
  • HaiKou, Hainan, China
  • +8 more
Jan 10, 2023

Immune Thrombocytopenia, Blood Coagulation Disorders, Thrombocytopenia Trial in Beijing (Sitagliptin, Danazol)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Apr 25, 2022

Immune Thrombocytopenia Trial in Beijing (Iguratimod)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 21, 2022

Immune Thrombocytopenia Trial (Zanubrutinib, Dexamethasone)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
May 6, 2022

Immune Thrombocytopenia Trial in Houston (Acetaminophen and Diphenhydramine Only Product)

Recruiting
  • Immune Thrombocytopenia
  • Acetaminophen and Diphenhydramine Only Product
  • Houston, Texas
    Texas Children's Hospital
Apr 11, 2022

Immune Thrombocytopenia Trial in Beijing (Zanubrutinib, Eltrombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
May 6, 2022

Primary Immune Thrombocytopenia Trial in Spain (Romiplostim plus dexamethasone, Dexamethasone)

Recruiting
  • Primary Immune Thrombocytopenia
  • Barcelona, Spain
  • +14 more
Dec 22, 2022

ITP, Immune Thrombocytopenia Trial in Beijing (Iguratimod, Danazol)

Recruiting
  • ITP
  • Immune Thrombocytopenia
  • Beijing, China
  • +1 more
Apr 29, 2022

Purpura, Thrombocytopenic, Idiopath Thrombocytopenic Purp, Aspirin Trial (Aspirin)

Not yet recruiting
  • Purpura, Thrombocytopenic
  • +2 more
  • (no location specified)
Mar 15, 2022

Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • potential biomarkers
  • Graz, Styria, Austria
    Pediatric Hematology-Oncology Outpatient Clinic
Sep 8, 2022

Immune Thrombocytopenia, Treatment Trial in Tianjin (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Treatment
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 19, 2022

Immune Thrombocytopenia, Bruton Tyrosine Kinase Trial in Beijing (Zanubrutinib)

Recruiting
  • Immune Thrombocytopenia
  • Bruton Tyrosine Kinase
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Mar 6, 2022

Primary Immune Thrombocytopenia (ITP) Trial (Combination of Rituximab with subcutaneous belimumab, Combination of Rituximab with

Not yet recruiting
  • Primary Immune Thrombocytopenia (ITP)
  • Combination of Rituximab with subcutaneous belimumab
  • Combination of Rituximab with subcutaneous placebo
  • (no location specified)
Apr 15, 2022

Immune Thrombocytopenia Trial in Korea, Republic of (LIV-GAMMA SN Inj.10%)

Completed
  • Immune Thrombocytopenia
  • LIV-GAMMA SN Inj.10%
  • Busan, Korea, Republic of
  • +10 more
Sep 30, 2022

Immune Thrombocytopenia, Autoimmune Hemolytic Anemia Trial in Toulouse (no specific intervention)

Recruiting
  • Immune Thrombocytopenia
  • Autoimmune Hemolytic Anemia
  • no specific intervention
  • Toulouse, France
    Service de Médecine Interne
Jan 24, 2022

Serum Interleukin 10 in Patients With ITP

Recruiting
  • Thrombocytopenia
  • Serum IL10 By ELISA
  • +2 more
  • Sohag, Egypt
    Faculty Of Medicine
Oct 24, 2022

Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia Trial (povetacicept)

Not yet recruiting
  • Immune Thrombocytopenia
  • +3 more
  • (no location specified)
Mar 9, 2023